Interleukin 1β decreases the GSH content and catalase activity in the human peritoneal mesothelial cells in vitro

Archivum Immunologiae et Therapiae Experimentalis

Volumn 48, Issue 3, 2000, Pages 205-209

  Grzybowski, Andrzej E ^a,b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b NONE   (Poland)

Author keywords

Antioxidants; Catalase; Dialysis; Inflammation; Interleukin 1; Superoxide

Indexed keywords

ANTIOXIDANT; CATALASE; FREE RADICAL; GLUTATHIONE; INTERLEUKIN 1; SUPEROXIDE DISMUTASE;

ARTICLE; DRUG EFFECT; EPITHELIUM CELL; HUMAN; IMMUNOLOGY; IN VITRO STUDY; METABOLISM; PERITONEUM;

ANTIOXIDANTS; CATALASE; EPITHELIAL CELLS; FREE RADICALS; GLUTATHIONE; HUMANS; INTERLEUKIN-1; PERITONEUM; SUPEROXIDE DISMUTASE;

EID: 0033643245     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. AEBI H. (1984): Catalase in vitro. Methods Enzymol., 103, 121-126.
2. BRAUNER A., HYLANDER B. and WRETLIND B. (1996): Tumor necrosis factor alpha, interleukin-1 beta and interleukin-1 receptor antagonist in dialysate and serum from patients on continuous ambulatory peritoneal dialysis. Am. J. Kidney Dis., 27, 402-408.
3. COENE M. C., VAN HOVE C., CLAEYES M. and HERMAN A. G. (1982): Arachidonic acid metabolism by cultured mesothelial cells. Biochim. Biophys. Acta, 710, 437-445.
4. DAS U. N. (1991): Interactions between essential fatty acids, eicosanoids, cytokines, growth factors and free radicals: relevance to new therapeutic strategies in rheumatoid arthritis and other collagen vascular diseases. Prostaglandins Leukot. Essent. Fatty Acids, 44, 201-210.
5. DAVIES S. J., SUASSUNA J., OGG C. S. and CAMERON J. S. (1989): Activation of immunocompetent cells in the peritoneum of patients treated with CAPD. Kidney Int., 36, 661-668.
6. DINARELLO C. A. (1984): Interleukin 1. Rev. Infect. Dis., 6, 51-95.
7. DOUVDEVANI A., RAPOPORT J., KONFORTY A., ARGOV S., OVNAT A. and CHAIMOVITZ C. (1994): Human peritoneal mesothelial cells synthesize IL-1α and β. Kidney Int., 46, 993-1001.
8. DURAK I., AKYOL O., BASESME E., CANBOLAT O. and KAVTCU M. (1994): Reduced erythrocyte defence mechanisms against free radical toxicity in patients with chronic renal failure. Nephron, 66, 76-80.
9. FIEREN M. W. (1996): Mechanisms regulating cytokine release from peritoneal macrophages during continuous ambulatory peritoneal dialysis. Blood Purif., 14, 178-187.
10. FREEMAN B. A. and CRAPO J. D. (1982): Free radicals and tissue injury. Lab. Invest., 47, 412-426.
11. GERWIN B., LECHNER J. F., REDDEL R. R., ROBERTS A. B., ROBBINS K. C., GABRIELSON E. W. and HARRIS C. C. (1987): Comparison of production of transforming growth factor-beta and platelet-derived growth factor by normal human mesothelial cells and mesothelioma cells lines. Cancer Res., 47, 6180-6184.
12. GRIFFITH O. W. (1980): Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal. Biochem., 106, 207-212.
13. GRZYBOWSKI A., BREBOROWICZ A., MARTIS L. and OREOPOULOS D. G. (1995): Antioxidant mechanisms (AM) in the mesothelial cells (MC) in conditions simulating peritoneal dialysis (abstract). J. Physiol. Pharmacol., 46, 98.
14. HARLAN J. M. and CALLAHAN K. S. (1984): Role of hydrogen peroxide in the neutrophil-mediated release of prostacyclin from cultured endothelial cells. J. Clin. Invest., 74, 442-448.
15. 2. J. Clin. Invest., 89, 794-802.
16. LEWIS S. L. and NORRIS P. J. (1990): Monocyte/macrophage function in CAPD patients. In COLES G. A., DAVIES M. and WILLIAMS J. D. (eds.): Host defence, nutrition and ultrafiltration. Contrib. Nephrol. Karger, Basel, 85, 1-9.
17. LOWRY O., ROSEBROUGH N., FARR A. and RANDALL R. (1951): Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275.
18. MCCORD J. M. and FRIDOVICH I. (1969): Superoxide dismutase. J Biol. Chem., 244, 6049-6055.
19. OMATA M., SANAKA T., MATSUZAWA T., NISHIMURA H., SHINOBE M., SATOH Y., HIGUCHI C. and NIHEI H. (1995): Increased cellular fibronectin (EDA(+) FN) in CAPD patients and its relation to oxidant injury (abstract). Perit. Dial. Int., 15, (suppl.), S80.
20. OWENS M. W. and GRISHAM M. B. (1993): Nitric oxide synthesis by rat pleural mesothelial cells: induction by cytokines and lipopolisaccharide. Am. J. Physiol., 265, L110-116.
21. RADEKE H. H., MEIER B., TOPLEY N., FLÖGE J., HABERMEHL G. G. and RESCH K. (1990): Interleukin-1α and tumor necrosis factor-α induce oxygen radical production in mesangial cells. Kidney Int., 37, 767-775.
22. SHALDON S. (1989): The interleukin hypothesis: a reappraisal after 6 years. Semin. Dial., 2, 172-175.
23. STYLIANOU E., JENNER L., DAVIES M., COLES G. A. and WILLIAMS J. D. (1990): Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int., 37, 1563-1570.
24. 2 release from bovine pulmonary artery endothelial cells induced by TGF-β1. Am. J. Physiol., 265, L622-L626.
25. TIETZE F. (1969): Enzymic method for quantitive determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem., 27, 502-522.
26. TOPLEY N., COLES G. A. and WILLIAMS J. D. (1994): Biocompatibility studies on peritoneal cells. Perit. Dial. Int., 14 (suppl.3), S21-28.
27. TOPLEY N., JORRES A., LUTTMANN W., PETERSEN M. M., LAND M. J., THIERAUCH K. H., MUELLER C., COLES G. A., DAVIES M. and WILLIAMS J. D. (1993): Human peritoneal mesothelial cells synthesize interleukin-6: induction by IL-1β and TNF-α. Kidney Int., 43, 226-233.
28. VAN BRONSWIJK H., VERBRUGH H. A., Bos H. J., HEEZIUS E. C., OE P. L., VAN DER MEULEN J. and VERHOEF J. (1989): Cytotoxic effects of commercial ambulatory peritoneal dialysis (CARD) fluids and of bacterial exoproducts on human mesothelial cells in vitro. Perit. Dial. Int., 9, 192-202.
29. VANELLA A , GEREMIA E., PINTURO R., TIRIOLO P., LIUZZO G., TlRlOLO C., CUSTORELLA A., CONDORELLl G. and GlGLIO A. (1983): Superoxide dismutase activity and reduced glutathione content in erythrocytes of uremic patients on chronic dialysis. Acta Haemat., 70, 312-315.
30. Wu Y. J., PARKER L. M., BINDER N. E., BECKETT M. A., SINARD J. H., GRIFFITHS C. T. and RHEINWALD J. G. (1982): The mesothelial keratins: a new family of cytoskeletal proteins identified in cultured mesothelial cells and non-keratinizing epithelia. Cell, 31, 693-703.
31. ZEMEL D., IMHOLZ A. L., DEWAART D. R., DINKLA C., STRUIJK D. G. and KREDIET R. T. (1994): Appearance of tumor necrosis factor alpha and soluble TNF-receptors I and II in peritoneal effluent of CAPD. Kidney Int., 46, 1422-1430.
32. ZEMEL D. and KREDIET R. T. (1996): Cytokine patterns in the effluent of continuous ambulatory peritoneal dialysis: relationship to peritoneal permeability. Blood Purif., 14, 198-216.
33. ZEMEL D., TEN BERGE R. J. M., STRUIJK D. G. BLOEMENA E., KOOMEN G. C. and KREDIET R. T. (1992): Interleukin-6 in CAPD patients without peritonitis: relationship to the intrinsic permeability of the peritoneal membrane. Clin. Nephrol., 37, 97-103.
34. ZIMMERMAN R. J., CHAN A. and LEADON S. A. (1989): Oxidative damage in murine tumor cells treated in vitro by recombinant human tumor necrosis factor. Cancer Res., 49, 1644-1648.